MedPath

YSOPIA Bioscience

YSOPIA Bioscience logo
🇫🇷France
Ownership
Private
Established
2010-01-01
Employees
11
Market Cap
-
Website
https://ysopia.bio

Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults

Phase 1
Completed
Conditions
Obesity
Metabolic Disease
Interventions
Drug: Placebo
First Posted Date
2020-12-10
Last Posted Date
2021-07-13
Lead Sponsor
YSOPIA Bioscience
Target Recruit Count
38
Registration Number
NCT04663139
Locations
🇺🇸

Celerion, Lincoln, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath